✦ LIBER ✦

Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial

✍ Scribed by Fuyuhiko Motoi MD, Kazuyuki Ishida MD, Fumiyoshi Fujishima MD, Shigeru Ottomo MD, Masaya Oikawa MD, Takaho Okada MD, Hiromune Shimamura MD, Shinichi Takemura MD, Fuminori Ono MD, Masanori Akada MD, Kei Nakagawa MD, Yu Katayose MD, Shinichi Egawa MD, Michiaki Unno MD…show all 14hide

Book ID: 120965405
Publisher: Springer
Year: 2013
Tongue: English
Weight: 342 KB
Volume: 20
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-013-3129-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of Life in a Prospective, Multic

Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma

✍ Serrano, Pablo E.; Herman, Joseph M.; Griffith, Kent A.; Zalupski, Mark M.; Kim, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 723 KB

A Multi-Institutional Phase II Trial of

A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma

✍ Mark S. Talamonti; William Small; Mary F. Mulcahy; Jeffrey D. Wayne; Vikram Atta 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 298 KB

A Phase 1/2 and Biomarker Study of Preop

A Phase 1/2 and Biomarker Study of Preoperative Short Course Chemoradiation With Proton Beam Therapy and Capecitabine Followed By Early Surgery for Resectable Pancreatic Ductal Adenocarcinoma

✍ Hong, Theodore S.; Ryan, David P.; Borger, Darrell R.; Blaszkowsky, Lawrence S.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 496 KB